@ARTICLE{
author={Gisslinger Heinz,Gotic Mirjana D,Holowiecki Jerzy,Penka Miroslav,Thiele Juergen,Kvasnicka Hans-Michael,Kralovics Robert,Petrides Petro E},
year={2013},
title={Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial},
journal={BLOOD},
volume={121},
number={10},
pages={1720-1728},
document_type={Article},
} 

@ARTICLE{
author={Petrides Petro E,Gotic Mirjana D,Penka Miroslav,Holowiecki Jercy,Thiele Juergen,Kvasnicka HM,Kralovics Robert,Gisslinger Heinz},
year={2009},
title={Anahydret: A European multicenter prospective phase 3-study: Non-inferiority of anagrelide compared to hydroxyurea in newly who-diagnosed et patients},
journal={HAEMATOLOGICA-THE HEMATOLOGY JOURNAL},
volume={94},
number={},
pages={1089-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Gisslinger Heinz,Gotic Mirjana D,Petrides Petro E},
year={2008},
title={Final Results of the ANAHYDRET-Study: Non-Inferiority of Anagrelide Compared to Hydroxyurea in Newly Diagnosed WHO-Essential Thrombocythemia Patients},
journal={BLOOD},
volume={112},
number={11},
pages={247-247},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Gisslinger Heinz,Kralovics Robert,Gotic Mirjana D,Holowiecki Jercy,Penka Miroslav,Widmann Rudolf,Petrides Petro E},
year={2007},
title={Non-inferiority of anagrelide compared to hydroxyurea in newly diagnosed patients with essential thrombocythemia: The ANAHYDRFT-Study},
journal={BLOOD},
volume={110},
number={11},
pages={1038A-1038A},
document_type={Meeting Abstract},
}